rTMS treatment + Ketamine for major depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Apr 2020: Trial registered, NCT04352621

The trials

NCT04352621: Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)

State
State not given
Phase
Phase 4
People
20 planned
Started
1 May 2020
Primary completion
1 May 2022
Arms
Ketamine plus rTMS
Results
None posted
  1. 20 Apr 2020: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.